Dr. Christopher J. Grilli
Overview
Christopher Grilli is an Interventional Radiologist in Newark, Delaware. Dr. Grilli has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in Liver Embolization. His top areas of expertise are Ascites, Endometrial Cancer, Lung Cancer, Liver Embolization, and Gastrostomy.
His clinical research consists of co-authoring 17 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Liver Embolization.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4755 Ogletown-Stanton VIR1E20 Road, Newark, DE 19718
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Penn Interventional Radiology HUP
Terence Gade is an Interventional Radiologist in Philadelphia, Pennsylvania. Dr. Gade is rated as a Distinguished provider by MediFind in Liver Embolization. His top areas of expertise are Liver Cancer, Ascites, Bile Duct Obstruction, Liver Embolization, and Thrombectomy. Dr. Gade is currently accepting new patients.
Penn Interventional Radiology HUP
Michael Soulen is an Interventional Radiologist in Philadelphia, Pennsylvania. Dr. Soulen is rated as a Distinguished provider by MediFind in Liver Embolization. His top areas of expertise are Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Liver Embolization, and Thrombectomy. Dr. Soulen is currently accepting new patients.
Penn Interventional Radiology HUP
Stephen Hunt is an Interventional Radiologist in Philadelphia, Pennsylvania. Dr. Hunt has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in Liver Embolization. His top areas of expertise are Pleurisy, Pleural Effusion, Fibrolamellar Carcinoma, Liver Embolization, and Thrombectomy. Dr. Hunt is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AscitesDr. Grilli isDistinguished. Learn about Ascites.
- Advanced
- Deep Vein ThrombosisDr. Grilli isAdvanced. Learn about Deep Vein Thrombosis.
- Endometrial CancerDr. Grilli isAdvanced. Learn about Endometrial Cancer.
- Fibrolamellar CarcinomaDr. Grilli isAdvanced. Learn about Fibrolamellar Carcinoma.
- Liver EmbolizationDr. Grilli isAdvanced. Learn about Liver Embolization.
- Lung CancerDr. Grilli isAdvanced. Learn about Lung Cancer.
- Thyroid NoduleDr. Grilli isAdvanced. Learn about Thyroid Nodule.
- Experienced
- Aberrant Subclavian ArteryDr. Grilli isExperienced. Learn about Aberrant Subclavian Artery.
- Acro-Pectoro-Renal Field DefectDr. Grilli isExperienced. Learn about Acro-Pectoro-Renal Field Defect.
- Acropectoral SyndromeDr. Grilli isExperienced. Learn about Acropectoral Syndrome.
- Adams-Oliver SyndromeDr. Grilli isExperienced. Learn about Adams-Oliver Syndrome.
- Alcoholic CirrhosisDr. Grilli isExperienced. Learn about Alcoholic Cirrhosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Grilli isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.